Short answer
OmniAb, Inc. (OABI) filed an 8-K current report with the SEC on July 13, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). Amechi Nwachuku appointed COO effective July 13, 2026, adding senior commercial leadership across life sciences and diagnostics.
OmniAb, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Amechi Nwachuku appointed COO effective July 13, 2026, adding senior commercial leadership across life sciences and diagnostics
- Initial base salary $445,000, with 45% target annual bonus and $20,000 signing bonus
- 800,000 stock options granted August 1, 2026, vesting over four years with 12.5% vesting after six months
- Change-in-control protection includes one year’s salary, one year’s target bonus, health premiums, and accelerated time-based award vesting
- Appointment aligns executive incentives with long-term shareholder value but creates meaningful dilution and severance obligations
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other OmniAb, Inc. 8-K filings
Get the next OABI 8-K as it lands
Follow OABI for push alerts, or ask the research agent what this filing means.